261 related articles for article (PubMed ID: 28844444)
21. Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
Belcaro G; Dugall M; Hu S; Feragalli B; Cotellese R; Ledda A; Corsi M; Ricci A; Ippolito E; Errichi BM; Cornelli U; Cesarone MR; Hosoi M
Minerva Cardioangiol; 2018 Jun; 66(3):238-245. PubMed ID: 29795059
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis.
Galanaud JP; Ducruet T; Kahn SR;
J Thromb Haemost; 2020 Dec; 18(12):3309-3315. PubMed ID: 32898930
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis.
Zhang J; Ma F; Yao J; Hao B; Xu H; Guo X; Gao H; Yang T
Thromb Res; 2022 Jun; 214():68-75. PubMed ID: 35490647
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry.
Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
Heart Vessels; 2019 Apr; 34(4):669-677. PubMed ID: 30293163
[TBL] [Abstract][Full Text] [Related]
25. Low incidence of post-thrombotic syndrome in patients treated with new oral anticoagulants and percutaneous endovenous intervention for lower extremity deep venous thrombosis.
Sharifi M; Freeman W; Bay C; Sharifi M; Schwartz F
Vasc Med; 2015 Apr; 20(2):112-6. PubMed ID: 25832599
[TBL] [Abstract][Full Text] [Related]
26. The post thrombotic syndrome.
Kahn SR
Thromb Res; 2011 Feb; 127 Suppl 3():S89-92. PubMed ID: 21262451
[TBL] [Abstract][Full Text] [Related]
27. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
[TBL] [Abstract][Full Text] [Related]
28. Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.
Méan M; Limacher A; Alatri A; Aujesky D; Mazzolai L
Thromb Haemost; 2018 Aug; 118(8):1419-1427. PubMed ID: 29960276
[TBL] [Abstract][Full Text] [Related]
29. Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS Registry.
Hach-Wunderle V; Bauersachs R; Gerlach HE; Eberle S; Schellong S; Riess H; Carnarius H; Rabe E
J Vasc Surg Venous Lymphat Disord; 2013 Jan; 1(1):5-12. PubMed ID: 26993886
[TBL] [Abstract][Full Text] [Related]
30. Post-thrombotic syndrome: current prevention and management strategies.
Guanella R; Kahn SR
Expert Rev Cardiovasc Ther; 2012 Dec; 10(12):1555-66. PubMed ID: 23253279
[TBL] [Abstract][Full Text] [Related]
31. The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.
Prandoni P; Ageno W; Ciammaichella M; Mumoli N; Zanatta N; Imberti D; Visonà A; Bucherini E; Di Nisio M; Noventa F;
Intern Emerg Med; 2020 Apr; 15(3):447-452. PubMed ID: 31667697
[TBL] [Abstract][Full Text] [Related]
32. Clinical biomarkers and management of post thrombotic syndrome.
Biondi A; Strano G; Ruggeri L; Vadala S; Tropea A; Basile F
Front Biosci (Elite Ed); 2010 Jan; 2(2):771-8. PubMed ID: 20036921
[TBL] [Abstract][Full Text] [Related]
33. Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.
Metz AK; Diaz JA; Obi AT; Wakefield TW; Myers DD; Henke PK
Methodist Debakey Cardiovasc J; 2018; 14(3):173-181. PubMed ID: 30410646
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children.
Avila L; Amiri N; De R; Vincelli J; Pullenayegum E; Williams S; Brandão LR
Blood Adv; 2021 Oct; 5(19):3737-3747. PubMed ID: 34474480
[TBL] [Abstract][Full Text] [Related]
35. Post-thrombotic syndrome: prevalence, prognostication and need for progress.
Prandoni P; Kahn SR
Br J Haematol; 2009 May; 145(3):286-95. PubMed ID: 19222476
[TBL] [Abstract][Full Text] [Related]
36. Post-thrombotic syndrome.
Visonà A; Quere I; Mazzolai L; Amitrano M; Lugli M; Madaric J; Prandoni P;
Vasa; 2021 Sep; 50(5):331-340. PubMed ID: 33720757
[No Abstract] [Full Text] [Related]
37. Prevalence of post-thrombotic syndrome in a cohort of upper extremity vein thrombosis.
Hervé H; Toquet C; Ploton G; Connault J; Gautier G; Raimbeau A; Bergère G; Hersant J; Durant C; Artifoni M; Brebion N; Kubina JM; Pistorius MA; Espitia O
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):111-117.e3. PubMed ID: 33894342
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants.
Spiezia L; Campello E; Simion C; Poretto A; Dalla Valle F; Simioni P
Angiology; 2022 Aug; 73(7):649-654. PubMed ID: 34989625
[TBL] [Abstract][Full Text] [Related]
39. Incidence and cost burden of post-thrombotic syndrome.
Ashrani AA; Heit JA
J Thromb Thrombolysis; 2009 Nov; 28(4):465-76. PubMed ID: 19224134
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of natural history of deep vein thrombosis: early predictors of poor late outcomes.
van Rij AM; Hill G; Krysa J; Dutton S; Dickson R; Christie R; Smillie J; Jiang P; Solomon C
Ann Vasc Surg; 2013 Oct; 27(7):924-31. PubMed ID: 23816387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
